| Expression pattern: |
UP |
| Associated gene: |
SMAD2 |
| Associated microRNA: |
miR-136-5p |
| Biological function: |
promotes proliferation, migration, invasion and EMT of nasopharyngeal carcinoma cells |
| Molecular mechanism: |
ceRNA mechanism: circFOXM1 sponges miR-136-5p to upregulate SMAD2 and promote EMT |
| Biological pathway or process: |
EMT (promotes); proliferation (promotes); migration (promotes); invasion (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; RNase R Treatment; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; Transwell Assay; Wound Healing Assay; Western Blot; Clinical Sample Validation; Survival Analysis; Bioinformatics Analysis |
| Clinical significance: |
High expression of circFOXM1 indicates a poor prognosis for nasopharyngeal carcinoma; circFOXM1 expression is related to clinical stage |
| Description: |
circFOXM1 is up-regulated in nasopharyngeal carcinoma and mainly localized in the cytoplasm. It promotes NPC cell proliferation, migration, invasion and EMT by acting as a ceRNA that sponges miR-136-5p to increase SMAD2 expression. High circFOXM1 expression is associated with advanced stage and poor prognosis. |
| Confidence score: |
0.8396 |